VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AHG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AHGAkso Health Group
$1.52$513M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAHGCash Flow

Akso Health Group (AHG) Cash Flow Statement

11Y historyFree accessUpdated daily

Despite reporting a $3.0M free cash flow surplus in 2025Q4, the company's liquidity is heavily influenced by volatile working capital shifts and significant acquisition-related outflows of $18.8M.

AHG Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricMar'25Mar'24Mar'23Mar'22Mar'21Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15
Cash from Operations1.18M1.35M-3.25M-8.63M10.06M-55.87M-1.73M87.72M8.19M7.03M2.59M
Operating CF Margin %7.97%55.97%-24.68%-143.81%573.15%-807.95%-46.85%81.79%35.73%59.07%55.67%
Operating CF Growth %-12.88%141.53%62.29%-185.78%118%-3127.23%-101.97%971.13%16.57%171.62%-
Net Income-135.47M-9.12M-13.08M-16.85M-34.72M-71.2M5.53M65.51M8.57M3.54M-350.17K
Depreciation & Amortization2.15M0018.39K15.16K580.5K406.8K174.38K92.22K61.39K19.7K
Stock-Based Compensation000391.63K55.47K347.47K6.59M1.83M000
Deferred Taxes-30.8M00026.76M3.58B-3.72B415.62K135.64K-366.5K-218.95K
Other Non-Cash Items162.28M8.41M11M10.38M-3.16M-3.54B3.73B-525.91K320.09K-243.68K405.28K
Working Capital Changes3.02M2.06M-1.17M-2.56M21.11M-30.9M-15.34M20.32M-608.99K3.79M3.14M
Change in Receivables-859.54K327.19K-8.1M13.89K-25.43K-183.91K-418.64K0000
Change in Inventory01.5M6.11M-7.8M20.52M176.6K00000
Change in Payables417.18K166.04K712.88K-104.24K-82.1K-176.6K00000
Cash from Investing-105.91M-54.72M18.47M-19.96M-66212.78M-68.11M-27.62M-287.76K-120.46K-224K
Capital Expenditures-154.46K00-4.86K0-314.52K-944.81K-456.03K-287.76K-120.46K-224K
CapEx % of Revenue1.05%--0.08%-4.55%25.57%0.43%1.26%1.01%4.82%
Acquisitions-----------
Investments000001.6M30.79M0000
Other Investing-12.01M-54.72M18.47M-19.96M-66227.68M-50.66M-27.17M000
Cash from Financing195.88M131.65M-27.51M34.78M-9.04M-3.97M-29.38K47.52M4.29M243.27K-1.41M
Debt Issued (Net)-----------
Equity Issued (Net)195.88M139.34M010.02M5-2.67M-1.32M43.27M2M00
Dividends Paid000000-19.55M0000
Share Repurchases00000-2.67M-1.32M0000
Other Financing00034.76M962.77K-1.3M838.62K4.24M2.29M243.27K-1.41M
Net Change in Cash90.03M77.01M-12.73M6.8M4.2M-46.45M-75.25M113.39M11.41M6.86M954.68K
Free Cash Flow1.02M1.35M-3.25M-8.63M10.06M-56.18M-2.68M87.27M7.9M6.9M2.36M
FCF Margin %6.92%55.97%-24.68%-143.89%573.15%-812.5%-72.41%81.36%34.48%58.05%50.85%
FCF Growth %-24.31%141.53%62.32%-185.83%117.9%-1999.5%-103.07%1004.37%14.44%192.27%-
FCF per Share0.000.06-0.43-1.301.85-10.37-0.4616.481.481.300.44
FCF Conversion (FCF/Net Income)-0.01x-0.14x2.39x0.51x-0.29x0.78x-0.31x1.34x0.96x1.99x-7.39x
Interest Paid0111.56K336.59K676.89K02.41M00000
Taxes Paid2.98K24.99K17.55K92.82K03.21M12.25M1.02M300.6K00

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Unsustainable operational cash burn

Earnings Disconnect Masks Cash Reality

As reported in financial statements, AHG exhibits a profound divergence between net income and operating cash flow, with the company recording a $67.2M net loss in 2025Q4 while simultaneously reporting positive operating cash flow, suggesting that non-cash items or working capital shifts are heavily distorting performance.

The persistent gap between accounting losses and cash generation warrants extreme caution, as it implies that the company's reported cash flow may not be derived from core operational profitability. Investors should monitor whether these cash inflows are sustainable or merely temporary artifacts of aggressive working capital management.

FCF Volatility Reflects Operational Instability

Based on AHG's reported figures, free cash flow has swung violently from a $959.6K deficit in 2023Q4 to a $3.0M surplus by 2025Q4, indicating that the company's ability to generate self-sustaining cash remains highly erratic and disconnected from its underlying negative net income trajectory.

The lack of a consistent free cash flow trend suggests that the business model is currently unable to fund its own operations without external capital or balance sheet manipulation. This volatility makes it difficult to project a path to long-term solvency based on current operational performance.

Acquisition Strategy Consumes Liquidity Reserves

According to recent SEC filings, AHG has prioritized aggressive capital deployment through acquisitions, with net cash outflows for acquisitions reaching $18.8M in 2025Q4, which significantly outpaces the company's ability to generate organic cash flow from its core e-commerce and consultancy service operations.

The reliance on inorganic growth through acquisitions appears to be a primary use of the company's cash pile, potentially masking the lack of organic operational success. Analysts should investigate whether these acquisitions are providing tangible synergies or if they are simply a mechanism to deploy capital in the absence of a viable internal growth strategy.

Working Capital Shifts Drive Liquidity

As indicated by the company's cash flow statements, working capital changes have frequently swung between positive and negative, including a $398.4K contribution in 2025Q4, which suggests that the company's cash position is highly sensitive to the timing of payables and receivables rather than operational efficiency.

The reliance on working capital fluctuations to bolster cash flow suggests that the company may be managing its cash position through the timing of vendor payments or customer collections. This approach is inherently fragile and may not be sustainable if suppliers or customers alter their payment terms.

AHG — Frequently Asked Questions

Quick answers to the most common questions about buying AHG stock.

How much cash does Akso Health Group (AHG) generate from operations?

Akso Health Group (AHG) generated $1.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Akso Health Group's free cash flow?

Akso Health Group (AHG) generated $1.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Akso Health Group's capital expenditure (CapEx)?

Akso Health Group (AHG) spent $0.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.